Cargando…

Personalized downstaging treatment with ADT, chemotherapy and add-on zimberelimab for very-high-risk clinically localized prostate cancer: A case report

Very-high-risk prostate cancer (PCa) is associated with poor prognosis. Radical prostatectomy (RP) is an option for selected high-risk PCa cases, especially in younger, healthier patients. However, a high Gleason score and high T stage can increase the risk of RP. Neoadjuvant therapy has been report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jie, Gu, Tengfei, Hu, Shengping, Wang, Liang, Chen, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	7300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907918/ https://www.ncbi.nlm.nih.gov/pubmed/36820603 http://dx.doi.org/10.1097/MD.0000000000032870

Ejemplares similares

Impact of neoadjuvant chemotherapy on survival prognosis and pathological downstaging in patients presenting with high-risk upper tract urothelial carcinoma: A protocol for systematic review and meta analysis
por: Li, Kun, et al.
Publicado: (2020)

Neoadjuvant chemotherapy before radical prostatectomy for locally advanced prostate cancer: Protocol for a systematic review and meta-analysis
por: Lin, Tianhai, et al.
Publicado: (2019)

Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy
por: Heo, Ji Eun, et al.
Publicado: (2019)

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients
por: Gu, Cheng-Yuan, et al.
Publicado: (2016)

Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer
por: Serra, Marcello, et al.
Publicado: (2020)

Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022)

Effect of prostate volume on the peripheral nerve block anesthesia in the prostate biopsy: A strobe-compliant study
por: Luan, Yang, et al.
Publicado: (2016)

Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer
por: Gu, Peng, et al.
Publicado: (2022)

Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer
por: Kim, Choung Soo, et al.
Publicado: (2017)

Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)

A very rare presentation of lung cancer: Metastases to the distal phalanx of index–case report
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2019)

Observation of complications assessed by Clavien-Dindo classification in different endoscopic procedures of benign prostatic hyperplasia: An observational study
por: Pan, Ting-ting, et al.
Publicado: (2023)

Prostate tuberculosis mimicking prostate cancer: Case report and literature review
por: Li, Yu, et al.
Publicado: (2023)

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies
por: Xu, Huan, et al.
Publicado: (2016)

Feasibility of anterior lobe-preserving transurethral enucleation and resection of prostate on improving urinary incontinence in patients with benign prostatic hyperplasia: A retrospective cohort study
por: Huang, Xin, et al.
Publicado: (2023)

The application of IL-10 and TNF-α in expressed prostatic secretions and prostatic exosomal protein in urine in the diagnosis of patients with chronic prostatitis
por: Yin, Lianli, et al.
Publicado: (2019)

Risk factors for bladder calculi in patients with benign prostatic hyperplasia
por: Huang, Wei, et al.
Publicado: (2017)

Diagnosis and treatment of gastrointestinal stromal tumor extending to prostate: A case report and literature review
por: Xu, Huan, et al.
Publicado: (2016)

The first case of bipolar transurethral resection of the prostate for giant prostatic hyperplasia: A case report
por: Cui, Deheng, et al.
Publicado: (2022)

Positive response of a recurrent clear cell sarcoma to anlotinib combined with chemotherapy: A case report
por: Tao, Junyue, et al.
Publicado: (2022)

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies
por: Dai, Xiaoyu, et al.
Publicado: (2016)

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2016)

Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
por: Park, Jee Soo, et al.
Publicado: (2019)

Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men
por: Han, Zihua, et al.
Publicado: (2017)

Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies
por: Liu, Tong-Zu, et al.
Publicado: (2017)

The primary treatment of prostate cancer with high-intensity focused ultrasound: A systematic review and meta-analysis
por: He, Yue, et al.
Publicado: (2020)

Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?: A prospective comparative study
por: Abdulwahab Al-radhi, Mohammed, et al.
Publicado: (2021)

Efficacy and safety of intra-arterial chemotherapy combined with intravesical chemotherapy for high-risk non-muscle invasive bladder cancer: A protocol for a systematic review and meta-analysis
por: Li, Xing, et al.
Publicado: (2019)

Loss of DNA mismatch repair proteins in prostate cancer
por: Sharma, Meenal, et al.
Publicado: (2020)

Characteristics of prostate biopsy in patients under the dutasteride treatment
por: Obinata, Daisuke, et al.
Publicado: (2022)

Statin Use Reduces Prostate Cancer All-Cause Mortality: A Nationwide Population-Based Cohort Study
por: Sun, Li-Min, et al.
Publicado: (2015)

Intraoperative Management of an Incidentally Identified Ectopic Ureter Inserting Into the Prostate of a Patient Undergoing Radical Prostatectomy for Prostate Cancer: A Case Report
por: Singhal, Udit, et al.
Publicado: (2015)

Contrast-enhanced ultrasound targeted versus conventional ultrasound guided systematic prostate biopsy for the accurate diagnosis of prostate cancer: A meta-analysis
por: Zhang, Ming, et al.
Publicado: (2022)

Transurethral 1470 nm diode laser vaporization versus plasma kinetic enucleation of the prostate for the treatment of benign prostatic hyperplasia: A retrospective study
por: Huang, Jiaguo, et al.
Publicado: (2023)

Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2015)

Increasing incidence of prostate cancer in Taiwan: A study of related factors using a nationwide health and welfare database
por: Lin, Po-Hung, et al.
Publicado: (2020)

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

The establishment and evaluation of a new model for the prediction of prostate cancer
por: Wang, Qi, et al.
Publicado: (2017)

Reimbursement and use of intensity-modulated radiation therapy for prostate cancer
por: Shahinian, Vahakn B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a12v9906ues71ramf64ouvk5un